ISSN:
1432-2072
Keywords:
Opioid receptors
;
Conditioned place preference
;
Dopamine D1 and D2 receptors
;
BNTX
;
NTB
;
Reinforcement
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The effects of the dopamin D1 antagonist SCH23390 and the D2 antagonist sulpiride on the rewarding effects of δ opioid receptor agonists were examined in mice. Both [d-Pen2, Pen5]enkephalin (DPDPE, 1–15 nmol, ICV), a selective δ1 opioid receptor agonist, and [d-Ala2]deltorphin II (DELT, 0.5–5 nmol, ICV), a selective δ2 opioid receptor agonist, produced a dose-dependent place preference in mice. The DPDPE (15 nmol, ICV)-induced place preference was abolished by BNTX (0.5 mg/kg, SC), a δ1 opioid receptor antagonist, but not by NTB (0.5 mg/kg, SC), a δ2 opioid receptor antagonist. In contrast, the DELT (5 nmol, ICV)-induced place preference was antagonized by NTB, but not BNTX. Pretreatment with SCH23390 (3 µg/kg, SC) abolished the DPDPE-induced place preference, but not affect the DELT-induced place preference. Moreover, pretreatment with sulpiride (40 mg/kg, SC) did not modify the place preference induced by DPDPE or DELT. In the present study, we found that the activation of both central δ1 and δ2 opioid receptors produced rewarding effects. Furthermore, these results suggest that the rewarding effects of δ1 opioid receptor agonist may be produced through activation of the central dopaminergic system, especially dopamine D1 receptors, whereas the rewarding effects of δ2 opioid receptor agonists may be produced by some other mechanism(s).
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1007/BF02246659
Permalink
